^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    M-Vax (DNP VACC)

    i
    Other names: DNP VACC, melanoma vaccine DNP VACC
    Associations

    News

    Trials
    Company:
    AVAX Technologies
    Drug class:
    Immunostimulant
    Related drugs:
    Associations

    News

    Trials
    over3years
    Reverse Vaccinology Approach in Constructing a Multi-Epitope Vaccine Against Cancer-Testis Antigens Expressed in Non-Small Cell Lung Cancer. (PubMed, Asian Pac J Cancer Prev)
    Overall, in silico evaluations show that Mvax is a potential immunotherapeutic agent against NSCLC.
    Journal
    |
    CD8 (cluster of differentiation 8) • CTAG1B (Cancer/testis antigen 1B) • CD4 (CD4 Molecule) • MAGEA4 (Melanoma antigen family A, 4) • MAGEA3 (MAGE Family Member A3)
    |
    M-Vax (DNP VACC)